产品摘要:Bevacizumab is a recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) in vitro and in vivo.assay systems.
产品特性:
| 产品名称 | : Xenofer injection |
| 通用名称 | : Iron Sucrose |
| 主要成分 | : 注射剂 |
| 包装规格 | : 1’s |
| 优势 | : 100mg/5ml |
| 生产地 | : 孟加拉 |
产品摘要:Sofosvel is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment.This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA European Commission for treatment of patients with a
产品特性:
| 产品名称 | : Sofosvel |
| 通用名称 | : Sofosbuvir 400mg + Velpatasvir 100 mg |
| 主要成分 | : 片剂 |
| 包装规格 | : 1×6’s |
| 优势 | : 400mg+ 100mg |
| 生产地 | : 孟加拉 |
产品摘要:Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying.
产品特性:
| 产品名称 | : Soforal |
| 通用名称 | : Sofosbuvir |
| 主要成分 | : 片剂 |
| 包装规格 | : 8’s |
| 优势 | : 400 mg |
| 生产地 | : 孟加拉 |
产品摘要:is the global first generic oral tablet for pan-genotypic Chronic Hepatitis C treatment.This combination (Sofosbuvir 400 mg + Valpatasvir 100 mg) drug has been approved by US FDA European Commission for treatment of patients with all genoty
产品特性:
| 产品名称 | : Sofosvel |
| 通用名称 | : Sofosbuvir 400mg + Velpatasvir 100 mg |
| 主要成分 | : 片剂 |
| 包装规格 | : 1×6’s |
| 优势 | : 400mg+ 100mg |
| 生产地 | : 孟加拉 |
产品摘要:Ribavirin is an anti-viral drug indicated for severe RSV infection (individually), Hepatitis C infection (used in conjunction with Peginterferon) and other viral infections. Ribavirin is a prodrug, which when metabolized resembles purine RN
产品特性:
| 产品名称 | : Copeg |
| 通用名称 | : Ribavirin |
| 主要成分 | : 片剂 |
| 包装规格 | : 20’s |
| 优势 | : 200 mg |
| 生产地 | : 孟加拉 |
产品摘要:Entecavir is a guanosine analogue with marked activity against HBV DNA polymerase. It is licensed for the treatment of chronic Hepatitis B virus infection in patients with compensated liver disease and evidence of acute viral replication, p
产品特性:
| 产品名称 | : Caviral |
| 通用名称 | : Entecavir |
| 主要成分 | : 片剂 |
| 包装规格 | : 1×10’s |
| 优势 | : 1×10’s |
| 生产地 | : 孟加拉 |
产品摘要:Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying. And Daclatasvir is a direct-acti
产品特性:
| 产品名称 | : Darvoni |
| 通用名称 | : Sofosbuvir 400 mg and Daclatasvir 60 mg |
| 主要成分 | : 片剂 |
| 包装规格 | : 1×6’s |
| 优势 | : Sofosbuvir 400 mg and Daclatasvir 60 mg |
| 生产地 | : 孟加拉 |
产品摘要:Daclavir (Daclatasvir) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a
产品特性:
| 产品名称 | : Daclavir |
| 通用名称 | : Daclatasvir |
| 主要成分 | : 片剂 |
| 包装规格 | : 1×10’s |
| 优势 | : 60 mg |
| 生产地 | : 孟加拉 |
产品摘要:Acyclovir is used to treat infections caused by certain types of viruses. It treats cold sores around the mouth (caused by herpes simplex ) shingles (caused by herpes zoster ) and chickenpox.it is available in two strengths in injectable
产品特性:
| 产品名称 | : Xovir IV Infusion |
| 通用名称 | : Acyclovir |
| 主要成分 | : IV Infusion |
| 包装规格 | : 1’s |
| 优势 | : 250 mg, 500 mg |
| 生产地 | : 孟加拉 |
